Pioneering New Medical Treatments Using 3D Technology: Learn about the exciting world of 3D printing at this FREE community health event.
WHEN: 4 March 2021, from 1pm-2pm (please arrive by 12.50pm to secure your seat in prior of the talk commencing).
WHERE: The City of Perth Library's Auditorium, 573 Hay St, Perth WA (note: this is not the State Library)
SIGN-UP:Via Eventbrite by visiting bit.ly/3DPrintMed
About this Event
Royal Perth Hospital is home to Australia's first Biomedical Engineering service, established in 1969. The Centre for Implant Technology & Retrieval Analysis (CITRA) provides a service to all patients in Western Australia, supplying patient-specific implants and 3D-printed surgical planning models for adult and paediatric patients to all of the major hospitals in Western Australia, both public and private. No hospital in Australia (and few in the world) has a comparable history or breadth of medical 3D printing experience.
In this talk, you will see examples of pioneering clinical cases being undertaken by CITRA which are enabled by 3D printing. You will also discover answers to important clinical questions such as:
✚ How many hammer strikes can a patient with a custom cranial implant withstand?
✚ Will my 3D printer still work after I set it on fire?
✚ Can you reverse-engineer surgical equipment from YouTube videos?
Dr David Morrison is the Senior Bioengineer at the Centre for Implant Technology & Retrieval Analysis (CITRA), located at Royal Perth Hospital. David has a B.Sc (Hons) and a PhD in Chemical Engineering from the University Of NSW. David has experience working for a licensed (TGA, FDA and CE-Mark) medical device manufacturer producing devices for the Australian and international markets.
Since joining Royal Perth Hospital as a Bioengineer in 2006, David has worked on the design and manufacture of custom-made medical devices, specialising in the provision of custom medical devices for neurosurgery, maxillofacial, spinal, orthopaedics and other surgical specialities as a statewide service.
David has been involved in two recent clinical trials evaluating new methods of cranial reconstruction and has been a co-investigator on successful competitive research grants totalling more than $950,000, including the 2020 RPH Research Foundation's inaugural Innovation and Impact Grant on Tissue Engineering using adult mesenchymal stem cells and 3D-printed scaffolds to accelerate complex wound healing. David led the team to produce 10,000 TGA-approved Face Shields for the COVID pandemic.